Company: MLSS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022276
Chunk: 97

Company: MILESTONE SCIENTIFIC INC.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 2
Chunk 97
---
The
following discussions of the financial condition and results of operations should be read in conjunction with the financial statements
and the notes to those statements contained in this report and in connection with management’s discussion and analysis and the audited
consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2024,
which was filed with the Securities and Exchange Commission, or SEC on April 15, 2025. Certain statements in this discussion and elsewhere
in this report constitute forward-looking statements, within the meaning of Section 21E of the Exchange Act, which involve risks and
uncertainties. The actual results may differ materially from those anticipated in these forward-looking statements.

OVERVIEW

Milestone Scientific is a biomedical technology company
that patents, designs, develops, and commercializes innovative diagnostic and therapeutic injection technologies for medical and dental
applications. Since our inception, we have pioneered proprietary computer-controlled injection systems that are proven, reliable, and
well established in clinical use. Our common stock has been listed on the NYSE American since June 1, 2015, under the symbol “MLSS.”
The Company’s mission is to redefine the global standard of care for injection techniques by improving precision, efficiency, and
patient comfort while reducing the anxiety associated with traditional injections.

Our proprietary Dynamic Pressure Sensing (DPS®)
Technology System enables controlled flow and real-time pressure monitoring at the needle tip, facilitating safer and more consistent
drug delivery and fluid aspiration. This platform supports multiple medical and dental applications, including accurate epidural space
identification in regional anesthesia procedures.

In dentistry, our Wand® device—marketed
as CompuDent® and STA Single Tooth Anesthesia System®—is a single-use disposable handpiece suitable for all local anesthetic
procedures. The dental systems are marketed in the United States, Canada, and more than 40 other countries. In medicine, our CompuFlo®
Epidural Computer Controlled Anesthesia System has received FDA 510(k) clearance for use in the lumbar, thoracic, and cervical thoracic
junction regions of the spine, as well as CE Mark approval for commercialization across most European countries.

The recent issuance of a chronology-specific CPT code
by the American Medical Association represents a significant advancement, expanding reimbursement potential for epidural procedures using
the CompuFlo® system and supporting broader adoption in anesthesia and pain management practices across the United States. Milestone
Scient